Marker Therapeutics to Present at Three Upcoming Healthcare Conferences

Houston, Texas – November 08, 2018Marker Therapeutics, Inc. (NASDAQ: MRKR), a clinical-stage immuno-oncology company, today announced that its President and CEO, Peter L. Hoang, will participate in three upcoming healthcare conferences. Mr. Hoang will participate in a panel discussion titled “Drug Pricing and Development Challenges” at the CEO Life Sciences and Pharmaceuticals Symposium on November 13, 2018 in New York City, and will give corporate overviews at the Piper Jaffray 30th Annual Healthcare Conference on November 27, 2018 in New York City and at the Evercore ISI HealthconX Conference on November 28, 2018 in Boston.

 

CEO Life Sciences and Pharmaceuticals Symposium

Title: Drug Pricing and Development Challenges

Date: Tuesday, November 13, 2018

Time: 5:00pm – 6:30pm (EST)

Location: Yellow Room, 107 East 16th Street, New York City

 

Piper Jaffray 30th Annual Healthcare Conference

Date: Tuesday, November 27, 2018

Time: 12:00pm – 12:25pm (EST)

Location: Lotte New York Palace, Holmes 1, 4th Floor

 

Evercore ISI HealthconX Conference

Date: Wednesday, November 28, 2018

Time: 10:35am – 10:55am (EST)

Location: Boston Harbor Hotel, South Atlantic Room, 2nd Floor

 

Webcasts for the Piper Jaffray and Evercore ISI conferences will be made available at https://www.markertherapeutics.com/events/[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][mrkrdisclaimer]